[Serum levels of endothelial monocyte-activating polypeptide-II in type 2 diabetes mellitus].

Abstract

Endothelial dysfunction is implicated in the pathogenesis of macrovascular complications of diabetes and atherosclerosis. Endothelial monocyte-activating polypeptide-II (EMAP-II) is a multifunctional polypeptide with proinflammatory and antiangiogenic activity. The aim of this study was to investigate the serum level of EMAP-II in obese and nonobese… (More)

Topics

Cite this paper

@article{Mohylnytska2014SerumLO, title={[Serum levels of endothelial monocyte-activating polypeptide-II in type 2 diabetes mellitus].}, author={L A Mohyl'nyts'ka}, journal={Fiziolohichnyi zhurnal}, year={2014}, volume={60 1}, pages={84-90} }